Medicines pricing authority sets retail prices for key medicines | Latest India News

0

India’s drug pricing authority has set retail prices for several essential medicines, including widely prescribed painkillers and antibiotics, as well as drugs to treat type 2 diabetes and high blood pressure, according to people close to the government. case.

The retail price of 84 drug formulations was set by the National Pharmaceutical Pricing Authority (NPPA), the apex drug price regulatory authority under the Ministry of Chemicals and Fertilizers. Medications include the type 2 diabetes drug metformin, pain relievers like ibuprofen and diclofenac, and antibiotics amoxycillin and cefixime, among others.

Last week, the official gazette notified the details of the price check.

“In exercising the powers conferred by sections 5, 11 and 15 of the Medicines (Price Control) Order 2013, read with SO 1394(E) of 30 May 2013 and SO 701(E) of 10 March 2016 issued by the Government of India to the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority hereby fixes the price specified in column (6) of the table below as the retail price excluding tax on the products and services, if applicable, with respect to the formulation specified in the corresponding entry in column (2) of said table with the strength, unit and name of the manufacturer and marketing company, as specified read the NPPA notification signed by Deputy Director Prasenjit Das.

Prices apply only to the individual manufacturer or distributor mentioned in the notification.

Drug makers include Sun Pharma, Alkem, Zydus Healthcare, Akums Drugs and Pharmaceuticals, Glenmark Pharmaceutical, Torrent, Hetero, Micro Labs and others.

According to the notification, if the retail price of any of the formulations mentioned is not met, the manufacturer or marketing company concerned would be required to deposit the excess amount together with interest with the competent authorities.

The prices were set in accordance with the decision of the NPPA at its 99th executive meeting held on June 28, according to people familiar with the matter who declined to be named.

In October last year, the drug price regulator set price caps for 12 drugs prescribed to fight diabetes.

“To enable every Indian to afford medical treatment for diseases like Diabetes, NPPA has launched a successful step by setting price caps for 12 generic anti-diabetic drugs,” the regulator tweeted at the time.

Share.

Comments are closed.